Financhill
Back

Keros Therapeutics Stock Predictions

Keros Therapeutics Stock Forecast

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 17.1% based on the past 4 years of stock performance.
  • Keros Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
  • Is Keros Therapeutics Stock Undervalued?
    The current Keros Therapeutics [KROS] share price is $48.57. The Score for KROS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • KROS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Keros Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Keros Therapeutics has on average historically risen by 17.1% based on the past 4 years of stock performance.

Keros Therapeutics Stock Rating

Buy
56
Keros Therapeutics (KROS) is a Buy

Is Keros Therapeutics overpriced?

  • Keros Therapeutics has risen higher in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%

Keros Therapeutics Stock Price History

Is KROS stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and KROS is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
kerostx.com

52-Week Data

52-Week High:
73.00
52-Week Low:
27.02

Prediction Charts

Market Cap:
1.75B
Price in USD:
48.57
Volume:
322.08K
Beta:
1.14

Technical Analysis

SMA50:
48.17
SMA100:
55.48
SMA200:
48.03
52-Wk Change:
12.9%

Stock Predictions

  • Is Keros Therapeutics stock public?
    Yes, Keros Therapeutics is a publicly traded company.
  • What is the Keros Therapeutics stock quote today?
    The Keros Therapeutics stock price is 48.57 USD today.
  • How to buy Keros Therapeutics stock online?
    You can buy Keros Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jul-2 43.46 42.81 43.81 42.39
Jul-3 43.04 42.17 43.12 42.05
Jul-5 41.93 42.21 42.29 41.10
Jul-8 42.88 41.68 43.27 41.66
Jul-9 41.77 42.74 42.87 40.93
Jul-10 42.87 42.99 43.09 41.96
Jul-11 44.33 45.97 46.97 43.19
Jul-12 46.86 47.46 47.84 46.50
Jul-15 48.04 51.06 51.13 47.50
Jul-16 52.40 52.17 53.69 51.61
Jul-17 51.12 49.72 52.11 48.73
Jul-18 49.61 48.02 49.94 46.35
Jul-19 48.26 48.38 48.65 46.62
Jul-22 48.77 48.57 49.11 47.25

Keros Therapeutics Earnings

Keros Therapeutics Earnings Report: Per Share Keros Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Keros Therapeutics Forecast Revenue Growth

Keros Therapeutics Stock Analysis: Historical quarterly revenues per share for Keros Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.06 per share, an increase next quarter of $0.03 per share, an increase this year of $0.35 per share, and a decrease next year of $0.39 per share.

* Keros Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.